(PRWEB) April 23, 2013
The US Drug Watchdog is urging women who had what was supposed to be a minimally evasive surgery involving a transvaginal mesh product, and who have now developed a severe medical condition called erosion to call them immediately for the names of national caliber attorneys, who are all women, because the damages are gender specific, and severe. According to court records transvaginal mesh products were designed for women, who were suffering from pelvic organ prolapse, and or stress urinary incontinence. The procedure to install a transvaginal was supposed to be minimally invasive. The FDA is now saying transvaginal mesh failures is causing complications in patients such as erosion and infection. Women who experience transvaginal mesh failure may need to have numerous corrective surgeries. The US Drug Watchdog is now urging victims of a transvaginal mesh failure, that involve severe medical complications to contact them anytime at 866-714-6466.
Important note from the US Drug Watchdog: "Severe medical complications that have developed from a transvaginal mesh implant are impacting women nationwide from our nation's largest states like California, New York, Texas, and Florida, to our nation's smallest states by population such as Maine, Alaska, South Dakota, Montana, and all other US states. One of our biggest problems we hear about daily is the physician that initially did the transvaginal mesh implant will no longer return the frantic phone calls of their patients? This is why we are so passionate about making certain victims have the best possible attorneys."
The US Drug Watchdog is indicating symptoms of a transvaginal mesh implants may include:
U.S. District Court for the Southern District of West Virginia Multidistrict litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:
C.R. Bard, Inc., (MDL No. 2187);
American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Johnson & Johnson's Ethicon, Inc. (MDL No. 2327)